WebBravecto should be administered in accordance with the following table (corresponding to a dose of 25 - 56 mg fluralaner/kg body weight): For dogs above 56 kg body weight, use a combination of two pipettes that most closely matches the body weight. Method of administration to dogs: WebQualitative and quantitative composition - Bravecto® chewable tablets for dogs Qualitative and quantitative composition Each chewable tablet contains For the full list of excipients, see section "Pharmaceutical Particulars".

Clinical particulars - Bravecto® Spot-on Solution for Dogs

WebBRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, … WebBRAVECTO Spot-on for dogs is available in five sizes. The following table indicates the size of pipette to be used according to the body weight of the dog (equivalent to 25 - 56 mg fluralaner/kg body weight). Body weight (kg) of dog Administration guide: (volume and number of pipettes) Bravecto 112.5 mg for Very Small Dogs Bravecto 250 mg for phn idexx

Pharmacological particulars - Bravecto® Plus spot-on solution for …

WebBravecto is available as a chewable oral flea and tick treatment for dogs – providing 3 months protection. Active Ingredients Bravecto contains fluralaner. Indications For the control of flea and tick infestations on dogs. Treats and controls existing flea and tick infestations Sustained control of new flea and tick infestations for 3 months WebBRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. WebSAFETY DATA SHEET Bravecto ® Spot-On Solution Page 2 of 6 Response statement Storage Disposal P101: If medical advice is needed, have product container or label at … phn illawarra